Senseonics Holdings, Inc. and PHC Holdings Corporation To Host Joint Eversense CGM Virtual Analyst and Investor Event on March 15, 2023
17 Février 2023 - 02:00PM
Business Wire
Senseonics to report fourth quarter and full year 2022 financial
results after market close March 15, 2023 with results to be
discussed during the event
Senseonics Holdings, Inc. (NYSE American: SENS) a medical
technology company focused on the development and manufacturing of
long-term, implantable continuous glucose monitoring (CGM) systems
for people with diabetes, today announced plans to host a joint
virtual analyst and investor event alongside PHC Holdings
Corporation, the parent company of Senseonics’ global commercial
partner, Ascensia Diabetes Care, on Wednesday, March 15, 2023 at
6:30pm ET.
The event will include presentations from Koichiro Sato, Chief
Operating Officer of PHC Holdings Corporation and Robert Schumm,
President and Chief Executive Officer of Ascensia Diabetes Care on
the commercial partnership initiatives, clinical integration of
Eversense and presentations from Tim Goodnow, PhD, President and
Chief Executive Officer of Senseonics on the Eversense technology
portfolio and R&D roadmap and Rick Sullivan, Chief Financial
Officer of Senseonics, on fourth quarter and full year 2022
financial results and Senseonics’ near term financial guidance.
The webcast will be available on Senseonics Holdings, Inc.
website at www.senseonics.com by navigating to “Investor
Relations,” and then “Events & Publications,” and will be
archived there for future reference.
About Senseonics
Senseonics Holdings, Inc. is a medical technology company
focused on the development and manufacturing of glucose monitoring
products designed to transform lives in the global diabetes
community with differentiated, long-term implantable glucose
management technology. Senseonics’ CGM systems, Eversense®,
Eversense® XL and Eversense® E3 include a small sensor inserted
completely under the skin that communicates with a smart
transmitter worn over the sensor. The glucose data are
automatically sent every 5 minutes to a mobile app on the user’s
smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230217005098/en/
Senseonics Investor Contact Philip Taylor Gilmartin Group
415-937-5406 investors@senseonics.com
Senseonics (AMEX:SENS)
Graphique Historique de l'Action
De Mai 2023 à Juin 2023
Senseonics (AMEX:SENS)
Graphique Historique de l'Action
De Juin 2022 à Juin 2023
